Treatment for Complicated Urinary Tract Infections (UTIs)
The recommended treatment for complicated UTIs is a 7-day antimicrobial regimen for patients with prompt symptom resolution and 10-14 days for those with delayed response, with fluoroquinolones like levofloxacin being a preferred option when local resistance rates are low. 1
Initial Diagnostic Approach
- Obtain urine culture before initiating antimicrobial therapy due to the wide spectrum of potential infecting organisms and increased likelihood of antimicrobial resistance 2
- Common pathogens in complicated UTIs include E. coli, Proteus spp., Klebsiella spp., Pseudomonas spp., Serratia spp., and Enterococcus spp. 1
- If an indwelling catheter has been in place for ≥2 weeks and is still indicated, replace it before collecting the specimen to ensure accurate culture results 2
Treatment Duration Algorithm
Standard treatment duration:
Alternative shorter regimens:
- A 5-day regimen of levofloxacin 750mg once daily may be considered in patients with complicated UTI who are not severely ill 2, 3, 4
- A 3-day antimicrobial regimen may be considered for women aged <65 years who develop catheter-associated UTI without upper urinary tract symptoms after catheter removal 2
Antimicrobial Selection
First-line empiric therapy options:
- Intravenous options: ceftriaxone 1-2g once daily, piperacillin/tazobactam 2.5-4.5g three times daily, or aminoglycoside with or without ampicillin 1
- Oral options after clinical improvement: levofloxacin 500mg once daily, trimethoprim-sulfamethoxazole 160/800mg twice daily, or cefpodoxime 200mg twice daily 1
Fluoroquinolone considerations:
- Levofloxacin 500mg once daily for 7-14 days is effective for complicated UTIs 1, 5
- Only use fluoroquinolones when local resistance rates are <10%, the patient has no history of fluoroquinolone use in the past 6 months 1
- For severe infections, levofloxacin dose can be increased to 500mg twice daily for better coverage against less susceptible pathogens like Pseudomonas aeruginosa 6
Special Considerations
Male UTIs:
Catheter-associated UTIs:
Monitoring and Follow-up
- Reassess after 48-72 hours of empiric therapy to evaluate clinical response 1
- Adjust therapy based on culture and susceptibility results 2
- Consider urologic evaluation if the patient does not have prompt clinical response with defervescence by 72 hours 2
Common Pitfalls to Avoid
Do not:
- Use fluoroquinolones empirically if local resistance rates exceed 10% 1
- Use moxifloxacin for UTI treatment due to uncertainty regarding effective urine concentrations 2
- Neglect to adjust therapy based on culture results 2
- Use shorter treatment courses in males unless recent evidence supports it for your specific patient 1, 7
Always: